We are live on ! Find out more
DRZID

DePrince Race & Zollo Inc (DRZ) Portfolio holdings

AUM $5.29B
1-Year Est. Return 20.14%
This Fund
S&P 500
This Quarter Est. Return
-6.13%
1 Year Est. Return
+20.14%
3 Year Est. Return
+36.34%
5 Year Est. Return
+39.16%
10 Year Est. Return
+157.08%
AUM
$7.4B
AUM Growth
-$1.12B
Cap. Flow
-$592M
Cap. Flow %
-8%
Top 10 Hldgs %
13.14%
Holding
336
New
39
Increased
75
Reduced
165
Closed
54

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$88.5M
2
PX
Praxair Inc
PX
+$71.2M
3
KO icon
Coca-Cola
KO
+$67.1M
4
WBA
Walgreens Boots Alliance
WBA
+$51.4M
5
FLO icon
Flowers Foods
FLO
+$49.3M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$100M
2
URS
URS CORP
URS
+$86.4M
3
NTRS icon
Northern Trust
NTRS
+$82M
4
BNY
Bank of New York Mellon
BNY
+$78.1M
5
KSS icon
Kohl's
KSS
+$62.7M

Sector Composition

Rank Sector Weight
1 Financials 23.45%
2 Consumer Discretionary 14.54%
3 Industrials 14.15%
4 Energy 10.59%
5 Technology 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HHH icon
151
Howard Hughes
HHH
$3.98B
$10.3M 0.14%
72,089
-37,135
-34% -$5.44M
TPL icon
152
Texas Pacific Land
TPL
$23.6B
$10.3M 0.14%
479,997
+286,281
+148% +$5.87M
LDR
153
DELISTED
Landauer Inc
LDR
$9.68M 0.13%
293,366
-49,690
-14% -$1.91M
HVB
154
DELISTED
HUDSON VY HLDG CORP
HVB
$9.64M 0.13%
531,133
-48,310
-8% -$855K
AGO icon
155
Assured Guaranty
AGO
$3.29B
$9.61M 0.13%
433,440
-111,600
-20% -$2.6M
ASEI
156
DELISTED
AMER SCIENCE & ENGR INC.
ASEI
$9.46M 0.13%
170,894
-17,875
-9% -$1.1M
BKMU
157
DELISTED
Bank Mutual Corp
BKMU
$9.36M 0.13%
1,459,474
-347,689
-19% -$2.18M
YELL
158
DELISTED
Yellow Corporation Common Stock
YELL
$9.35M 0.13%
460,193
-317,320
-41% -$7.59M
FRME icon
159
First Merchants
FRME
$2.72B
$9.12M 0.12%
+450,990
New +$9.19M
CDI
160
DELISTED
CDI Corp.
CDI
$9.06M 0.12%
624,167
+245,451
+65% +$3.65M
GLPW
161
DELISTED
GLOBAL POWER EQUIPMENT GROUP INC COMMON NEW
GLPW
$9.05M 0.12%
607,558
+165,622
+37% +$2.67M
BAC icon
162
Bank of America
BAC
$453B
$9.01M 0.12%
528,660
-600,000
-53% -$9.55M
MGRC icon
163
McGrath RentCorp
MGRC
$2.94B
$8.92M 0.12%
260,740
+133,045
+104% +$4.86M
DGICA icon
164
Donegal Group Class A
DGICA
$692M
$8.75M 0.12%
569,486
-97,562
-15% -$1.51M
EFSC icon
165
Enterprise Financial Services Corp
EFSC
$2.41B
$8.71M 0.12%
521,195
-19,633
-4% -$345K
NTRI
166
DELISTED
NutriSystem, Inc.
NTRI
$8.43M 0.11%
548,343
-535,812
-49% -$8.89M
PSTB
167
DELISTED
Park Sterling Corp.
PSTB
$8.23M 0.11%
1,241,575
-15,227
-1% -$103K
EML icon
168
Eastern Company
EML
$155M
$7.96M 0.11%
498,917
-143,366
-22% -$2.26M
SNV
169
DELISTED
Synovus
SNV
$7.86M 0.11%
332,300
-134,700
-29% -$3.23M
GIFI
170
DELISTED
Gulf Island Fabrication
GIFI
$7.54M 0.1%
438,680
-97,234
-18% -$1.92M
BEBE
171
DELISTED
Bebe Stores Inc
BEBE
$7.33M 0.1%
315,930
-75,541
-19% -$2.14M
CFNL
172
DELISTED
Cardinal Financial Corp
CFNL
$7.32M 0.1%
428,798
-84,938
-17% -$1.52M
CTT
173
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
$7.12M 0.1%
649,841
-41,786
-6% -$500K
UTL icon
174
Unitil
UTL
$984M
$7.07M 0.1%
227,500
-35,070
-13% -$1.13M
BANC icon
175
Banc of California
BANC
$3.1B
$6.94M 0.09%
+596,615
New +$6.96M

Similar funds

DePrince Race & Zollo Inc (DRZ)'s Q3 2014 Portfolio in Review

As of Q3 2014, DePrince Race & Zollo Inc (DRZ) held 336 positions worth $7.4B, down 13% from $8.52B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

DePrince Race & Zollo Inc (DRZ) withdrew a net $592M in Q3 2014, closing 54 positions and reducing 165 holdings. Its most notable exit was Amgen, an estimated $100M position sold in full.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, DePrince Race & Zollo Inc (DRZ) opened a new position in Pfizer worth $88.5M.

  • DePrince Race & Zollo Inc (DRZ)'s largest Q3 2014 buy was Pfizer: 3,153,779 shares worth $88.5M.
  • DePrince Race & Zollo Inc (DRZ) added most to Emerson Electric in Q3 2014, an estimated $34.5M increase.
  • DePrince Race & Zollo Inc (DRZ)'s biggest Q3 2014 reduction was Teva Pharmaceuticals, cutting an estimated $44.4M.
  • DePrince Race & Zollo Inc (DRZ) fully exited Amgen in Q3 2014, selling an estimated $100M.
  • DePrince Race & Zollo Inc (DRZ)'s ten largest holdings make up 13% of its $7.4B portfolio in Q3 2014.
  • DePrince Race & Zollo Inc (DRZ) opened 39 new positions and closed 54 in Q3 2014.
  • DePrince Race & Zollo Inc (DRZ)'s portfolio value fell 13% quarter-over-quarter to $7.4B.

Based on DePrince Race & Zollo Inc (DRZ)'s 13F filing for Q3 2014, filed 30 Oct 2014.